Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

EGX:RMDA Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	44.01	36.18	64.69	52.36	66.96	14
Short-Term Investments	-	-	189.7	260.9	361.86	468.01
Cash & Short-Term Investments	44.01	36.18	254.39	313.25	428.82	482.01
Cash Growth	-59.54%	-85.78%	-18.79%	-26.95%	-11.04%	-0.12%
Accounts Receivable	1,073	1,027	791.26	353.74	276.6	265.96
Other Receivables	78.62	62.48	103.43	72.16	22.6	25.2
Receivables	2,386	2,178	1,582	1,344	923.28	684.61
Inventory	835.4	1,031	751.34	303.26	348.41	259.4
Prepaid Expenses	18.63	10.49	4.29	2.21	2.83	0.99
Other Current Assets	124.96	178.67	544.65	60.33	55.14	48.64
Total Current Assets	3,409	3,435	3,137	2,023	1,758	1,476
Property, Plant & Equipment	789.42	792.15	621.52	606.05	556.98	554.99
Other Intangible Assets	1,108	1,111	552.79	589.27	457.57	389.66
Total Assets	5,306	5,338	4,311	3,218	2,773	2,420
Accounts Payable	220.91	335.19	264.36	102.41	120.25	61.53
Accrued Expenses	154.45	154.76	115.09	76.44	62.92	37.31
Short-Term Debt	2,211	2,326	1,555	1,098	910.18	842.6
Current Portion of Long-Term Debt	-	-	-	-	-	21.95
Current Portion of Leases	4.01	6.76	4.48	4.81	3.66	3.13
Current Income Taxes Payable	141.01	116.58	98.78	60.59	53.71	33.49
Other Current Liabilities	172.53	43.98	117.77	30.67	31.23	22.05
Total Current Liabilities	2,904	2,984	2,155	1,373	1,182	1,022
Long-Term Leases	72.16	75.46	7.19	11.7	16.34	12.26
Long-Term Deferred Tax Liabilities	77.63	68.57	77.28	58.23	51.56	40.5
Total Liabilities	3,054	3,128	2,240	1,443	1,250	1,075
Common Stock	500	500	378.23	375	250	250
Additional Paid-In Capital	255.79	255.79	327.51	377.7	397.52	486.97
Retained Earnings	1,428	1,399	1,351	1,022	921.68	610.87
Treasury Stock	-	-	-26.23	-26.23	-65.93	-
Comprehensive Income & Other	25.75	13.04	13.31	14.21	15.31	0.28
Total Common Equity	2,210	2,168	2,044	1,763	1,519	1,348
Minority Interest	42.61	42.12	27.38	12.94	4.59	-2.62
Shareholders' Equity	2,252	2,210	2,072	1,775	1,523	1,345
Total Liabilities & Equity	5,306	5,338	4,311	3,218	2,773	2,420
Total Debt	2,287	2,409	1,566	1,114	930.18	879.94
Net Cash (Debt)	-2,243	-2,372	-1,312	-801.18	-501.37	-397.93
Net Cash Per Share	-1.11	-1.18	-0.65	-0.40	-0.26	-0.20
Filing Date Shares Outstanding	2,000	2,000	1,990	1,973	1,973	2,015
Total Common Shares Outstanding	2,000	2,000	1,990	1,973	1,956	2,015
Working Capital	505.07	450.99	981.82	650.11	576.53	453.59
Book Value Per Share	1.10	1.08	1.03	0.89	0.78	0.67
Tangible Book Value	1,102	1,057	1,491	1,173	1,061	958.45
Tangible Book Value Per Share	0.55	0.53	0.75	0.59	0.54	0.48
Land	18.64	18.64	18.64	18.64	18.64	18.64
Buildings	326.12	300.43	294.77	288.43	279.17	273.34
Machinery	735.9	726.8	646.31	585.04	533.6	491.55
Construction In Progress	72.59	94.15	33.46	38.09	12.86	27.04

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 5, 2026

Data Sources Report a data error